Frost & Sullivan a Media Partner with the 5th Annual Pharma Forecasting Excellence 2011 Conference

Sept. 13, 2011 - PRLog -- MOUNTAIN VIEW, Calif. – September 13, 2011 – The leading pharma meeting in the U.S., the 5th Annual Pharma Forecasting Excellence 2011 Conference, will provide attendees the chance to discover tactics to improve accuracy and eliminate uncertainty.  This will assist with strategies in modifying forecasting models to ensure judgmental movements do not harm precision.  This premier event will take place on October 4 to 5, 2011 at the Park Plaza Hotel in Boston.  

“The pharmaceutical landscape is in a constant state of flux,” said Frost & Sullivan Senior Industry Analyst Deborah Toscano.  “Numerous scientific, regulatory, societal and economical issues continually influence the market.  As such, it is crucial for anyone involved in forecasting to stay one step ahead of the game in order to formulate predictions with as much accuracy as possible.”

Key approaches to strengthening forecast protocols highlighted at the Pharma Forecasting Excellence 2011 Conference include optimizing modeling and tools, while improving accuracy in short term forecasts to better avoid costs down the line.  Another benefit will be a review of the impact of healthcare reform on forecasts, providing a snapshot of the global effects.    

Registrants will be afforded the prospect of developing new contacts via extensive networking opportunities to receive answers and insights from colleagues in the industry.  This event will also allow attendees the chance to benchmark their progress against peers as well as to determine best practices within the industry through interactive seminars, workshops and discussions.  Additionally, the Pharma Forecasting Excellence 2011 Conference will enlighten registrants on how to make the most of limited epidemiology in the healthcare environment.    

Among other industry leading participants, the event will feature insight from Genzyme, Blue Cross Blue Shield, Lilly, Daiichi-Sankyo, Amgen and Novartis regarding their perspective of upcoming changes in the healthcare market.  The Pharma Forecasting Excellence 2011 Conferences’ particular focus will be given to strategies for improving forecasting for new products, using better modeling to estimate uptake rates and driving volumes during launches.  Topics will include discussions of the expected growth in the emerging markets space and how improvements can be made in the use of local level epidemiology.    

“The value of any forecast lies in its perceived accuracy, which can be optimized by incorporating insight from multiple peers in the industry,” said Toscano.  “Pharma Forecasting for Excellence gives attendees the unique opportunity to capitalize on their knowledge and experience by interacting with other industry experts, which will help ensure comprehensive and accurate forecasts.”

The event features new speakers, new cast studies and a whole new layout, allowing guests to raise the bar in market planning.  For the full speaker lineup for the Pharma Forecasting Excellence 2011 Conference, agenda and more details please visit http://www.eyeforpharma.com/forecasting-excellence-usa.    

Following this theme, Frost & Sullivan recently launched the industry-wide Emerging Markets Growth Series which carries forward this drive for modernization and excellence in an age of a changing landscape in the marketplace.  This offering addresses the rise of the next generation economic powerhouses to assist global CEOs and their growth teams in identifying expansion opportunities in these Emerging Markets.  This unique offering discusses Latin America, Asia Pacific, Eastern Europe, Middle East, Africa, China and India markets.

About eyeforpharma
eyeforpharma is a division of a private company headquartered in London, United Kingdom.  The organization maintains offices in New York, South Africa and Australia, growing by at least 30 percent per year since its creation in 2002.  eyeforpharma’s strongest allies believe that there are many challenges in the pharma space that are bigger than just one company. Addressing and solving these problems and generating new opportunities require collaborative discussion and debate across the entire industry. eyeforpharma believes it is worth taking the effort to allow and foster just that, so their forums offer the platform for the kind of strategic thought leadership that can enable and trigger change. eyeforpharma’s commitment to the pharma industry is to be a conduit of high quality information and knowledge exchange among its dedicated professionals as they drive the industry in new and exciting directions.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

# # #

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's research and consulting services empower clients to generate, evaluate, and implement effective growth strategies.